Glucan-Based Macrophage Stimulators
作者： David L. Williams , Antje Mueller , William Browder
DOI: 10.1007/BF03259335
关键词: Pharmacotherapy 、 Sepsis 、 Surgical patients 、 Sepsis syndrome 、 Surgical Intensive Care 、 Intensive care medicine 、 Medicine 、 Macrophage 、 Critically ill
摘要: Sepsis and sepsis syndrome are significant causes of morbidity mortality in critically ill surgical patients. Despite technological therapeutic advances critical care, continues to be a pivotal factor 20 50% deaths intensive care units. It is clear that alternative approaches the prevention and/or treatment must found.
springer.com
sci-hub.se 参考文章(52)
Wise Wc, Halushka Pv, Cook Ja, Morris Dd, Moore Jn, Endotoxin-induced procoagulant activity, eicosanoid synthesis, and tumor necrosis factor production by rat peritoneal macrophages: effect of endotoxin tolerance and glucan. Circulatory shock. ,vol. 31, pp. 281- 295 ,(1990)
Zanetti G, Baumgartner Jd, Glauser Mp, Anti-endotoxin antibodies and other inhibitors of endotoxin. New horizons (Baltimore, Md.). ,vol. 1, pp. 110- ,(1993)
Holt Tm, Cook Ja, Dougherty Wj, Enhanced sensitivity to endotoxin induced by the RE stimulant, glucan. Circulatory shock. ,vol. 7, pp. 225- ,(1980)
Solomkin Js, Antrum Rm, Monocyte dysfunction in severe trauma: evidence for the role of C5a in deactivation. Surgery. ,vol. 100, pp. 29- 37 ,(1986)
S. M. Opal, G. J. Slotman, T. J. Iberti, J. C. Sadoff, M. P. Shelly, R. L. Greenman, W. A. Knaus, R A Balk, C. J. Fisher, J. F. Labrecque, J.-D. Dhainaut, J. P. Pribble, B. W. Thompson, M. J. Shapiro, H. D. Reines, E. C. Rackow, M. A. Catalano, Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome JAMA. ,vol. 271, pp. 1836- 1843 ,(1994)
Richard V. McCloskey, Richard C. Straube, Corazon Sanders, Craig R. Smith, Susan M. Smith, Treatment of Septic Shock with Human Monoclonal Antibody HA-1A Annals of Internal Medicine. ,(1994)
J de Felippe Junior, M da Rocha e Silva Júnior, FM Maciel, NF Mendes, None, Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan). Surgery gynecology & obstetrics. ,vol. 177, pp. 383- 388 ,(1993)
R Goldman, Induction of a beta-1,3-D-glucan receptor in P388D1 cells treated with retinoic acid or 1,25-dihydroxyvitamin D3. Immunology. ,vol. 63, pp. 319- 324 ,(1988)
J. Leibovici, Y. Stark, T. Eldar, G. Brudner, M. Wolman, Mechanism of the Inhibitory Effect of Levan on Experimental Tumors Recent results in cancer research. ,vol. 75, pp. 173- 179 ,(1980) , 10.1007/978-3-642-81491-4_27
J K Czop, K F Austen, Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor. Journal of Immunology. ,vol. 135, pp. 3388- 3393 ,(1985)